Internal Medicine, Hematology & Oncology · Minden, LA
NPI
1083618912
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
10600 Industrial Dr
Minden, LA, 71055
Phone (318) 239-4860
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
115,778 services
Medicare patients, 2024
810
Average age 74
Drug cost, 2024
$24.9M
6,217 prescriptions
Company payments, 2025
$4,619
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manish Dhawan was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 9,690 times for 15 patients. In total Manish Dhawan billed 115,778 services in 121 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 9,690 | 15 | $0.28 | $2,756 |
| J0897 Injection, denosumab, 1 mg | Office | 5,640 | 64 | $20.29 | $114K |
| J1756 Injection, iron sucrose, 1 mg | Office | 5,100 | 12 | $0.18 | $918 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,378 | 31 | $0.09 | $123 |
| 99214 Office E&M - Established | Office | 777 | 361 | $89.69 | $70K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 710 | 25 | $0.72 | $509 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 696 | 21 | $0.07 | $51.08 |
| 99213 Office E&M - Established | Office | 491 | 356 | $57.52 | $28K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 436 | 17 | $0.22 | $96.27 |
| 96372 Injection Administration | Office | 380 | 121 | $9.79 | $3,720 |
| 96413 Chemotherapy Administration | Office | 307 | 74 | $87.36 | $27K |
| 96367 Intravenous Infusion, Hydration | Office | 272 | 77 | $19.50 | $5,304 |
| 96375 Injection Administration | Office | 268 | 69 | $10.30 | $2,759 |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 230 | 13 | $1.45 | $334 |
| 99215 Office E&M - Established | Office | 215 | 145 | $125.48 | $27K |
By year: 2022 $3.9M for 251,754 services; 2023 $2.4M for 201,307 services; 2024 $1.5M for 115,778 services.
Medicare prescription drug claims, 2024
In 2024, the drug Manish Dhawan prescribed most often to Medicare patients was Lupron Depot (Leuprolide Acetate), with 318 prescriptions and refills. In total Manish Dhawan wrote 6,217 Medicare prescriptions that cost $24.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lupron Depot Leuprolide Acetate | 318 | 336 | 40 | $658K |
| Procrit Epoetin Alfa | 287 | 287 | 80 | $861K |
| Neulasta Onpro Pegfilgrastim | 199 | 199 | 55 | $1.5M |
| Potassium Chloride Generic | 168 | 264 | 56 | $3,964 |
| Anastrozole Generic | 149 | 348 | 41 | $3,094 |
| Prolia Denosumab | 138 | 828 | 107 | $232K |
| Ondansetron Odt Ondansetron | 131 | 131 | 82 | $2,021 |
| Hydroxyurea Generic | 122 | 185 | 30 | $2,219 |
| Eliquis Apixaban | 116 | 139 | 33 | $74K |
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 114 | 114 | 37 | $952 |
| Acyclovir Generic | 112 | 166 | 29 | $1,465 |
| Xtandi Enzalutamide | 111 | 111 | 19 | $1.6M |
| Jakafi Ruxolitinib Phosphate | 109 | 109 | 11 | $1.9M |
| Zarxio Filgrastim-Sndz | 101 | 101 | 23 | $172K |
| Abiraterone Acetate Generic | 98 | 98 | 13 | $82K |
Brand drugs: 3,099 claims; generic drugs: 3,118 claims; opioid claims: 131.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manish Dhawan $4,619 ($4,619 in general payments such as food, travel and fees) from 46 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,389.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 25 | $1,389 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $291 |
| Janssen Biotech, Inc. JNJ | 11 | $200 |
| GlaxoSmithKline, LLC. GSK | 9 | $196 |
| Daiichi Sankyo Inc. 4568.T | 7 | $146 |
| Array Biopharma Inc PFE | 6 | $124 |
| Astellas Pharma US Inc 4503.T | 6 | $123 |
| Genzyme Corporation SNY | 4 | $106 |
| Pfizer Inc. PFE | 6 | $101 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $95.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.